Prediction of lesion-based response to PRRT using baseline somatostatin receptor PET
The lesion-based molecular response to PRRT correlates with pretreatment somatostatin receptor PET uptake, particularly when expressed as tumor-to-liver SUV ratios (SUV<sub>maxT/L</sub> and SUV<sub>meanT/L</sub>).
Authors
- Caroline Burgard (ORCID: https://orcid.org/0000-0003-1522-8860)
- Arne Blickle (ORCID: https://orcid.org/0009-0009-2460-7249)
- Anas Aouf
- Samer Ezziddin (ORCID: https://orcid.org/0000-0003-4110-3375)
- Amir Sabet (ORCID: https://orcid.org/0000-0003-3027-5083)
- Moritz B. Bastian
- Florian Rosar (ORCID: https://orcid.org/0000-0002-2985-4099)
- Tilman Speicher
Institutions
- University Hospital Bonn (DE)
- Saarland University (DE)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-03-14
- DOI
- https://doi.org/10.3389/fmed.2025.1523862
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00